ScoreWhy is Inogen, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -204.84% of over the last 5 years
2
The company has declared Positive results for the last 4 consecutive quarters
- ROCE(HY) Highest at -13.46%
- NET SALES(Q) Highest at USD 92.28 MM
- PRE-TAX PROFIT(Q) Highest at USD -4.3 MM
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -27.51%, its profits have risen by 54%
4
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Below par performance in long term as well as near term
- Along with generating -27.51% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Inogen, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Inogen, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Inogen, Inc.
-29.68%
-0.29
53.26%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.75%
EBIT Growth (5y)
-204.84%
EBIT to Interest (avg)
-25.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.60
Sales to Capital Employed (avg)
1.59
Tax Ratio
1.91%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.90
EV to EBIT
-1.86
EV to EBITDA
-5.76
EV to Capital Employed
0.73
EV to Sales
0.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-39.46%
ROE (Latest)
-12.38%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
ROCE(HY)
Highest at -13.46%
NET SALES(Q)
Highest at USD 92.28 MM
PRE-TAX PROFIT(Q)
Highest at USD -4.3 MM
NET PROFIT(Q)
Highest at USD -4.15 MM
EPS(Q)
Highest at USD -0.15
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Inogen, Inc.
Net Sales
Highest at USD 92.28 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Pre-Tax Profit
Highest at USD -4.3 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -4.15 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.15
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
